Abstract:e13026 Background: Aromatase, encoded by CYP19A1 gene, is a rate-limiting enzyme in the conversion of androgens into estrogens. Given the critical role of CYP19A1gene in estrogen synthesis, the potential impact of genetic polymorphisms in CYP19A1 gene on the survival of breast cancer deserves further study. Methods: Rs1008805 polymorphism in CYP19A1 gene were genotyped on 406 Chinese Han women with stage I-II and operable stage III breast cancer. Associations were explored betweenrs1008805 genotypes and disease-free survival (DFS). Results: Totally, there were 200 (49.3%) patients with AA genotype, 169 (41.6%) with AG variant, and 37 (9.1%) carrying GG variant. No significant differences were found in DFS or 5-year survival rate among the whole population with these three genotypes. However, in postmenopausal women, rs1008805 genotypes were significantly related to worse DFS and 5-years DFS rate (AA versus AG versus GG: 63.1 months versus 54.3 months versus 13.7 months; 48.6% versus 46.0% versus 14.3%; P = 0.015). In addition, women with GG variant had a poorer DFS, 5-years DFS rate when compared with those carrying AG or AA genotype (GG versus AG or AA: 13.7 months versus 56.3 months; 0% versus 52.1%; HR, 2.462; 95 % CI, 1.310-4.628; P = 0.004). Being adjusted by patients features in multivariate analyses, GG genotype remained an independent prognostic factor for DFS (HR, 2.706; 95 % CI, 1.393-5.257; P = 0.003). Besides, women with the homozygous minor allele had a marginally improved DFS, 5-years DFS rate when compared with those carrying the common allele (GG versus AG or AA: 87.0 months versus 48.7 months; 60.3% versus 42.7 %; HR, 0.544; 95% CI, 0.295-1.003; P= 0.051). However, there was no relationship between GG genotype and DFS or 5-year DFS when adjusted by patients features in multivariate analyses. Conclusions: The present study demonstrated that homozygous minor allele of rs1008805 SNP in CYP19A1 gene was significantly related to a worse DFS in postmenopausal women with early breast cancer. This founding is novel, if confirmed, CYP19A1 rs1008805 genotypes may turned to be a prognostic biomarker for early breast cancer.

A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor is Associated with Breast Cancer Susceptibility and Prognosis

A Genetic Polymorphism (Rs17251221) In The Calcium-Sensing Receptor Is Associated With Ovarian Cancer Susceptibility

Polymorphisms of a Novel Long Non-Coding RNA RP11-108K3.2 with Colorectal Cancer Susceptibility and Their Effects on Its Expression

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

Association Between Mitogen-Activated Protein Kinase Kinase Kinase 1 Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 20 Case-Control Studies

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population

Association Between a Novel Polymorphism (rs2046210) of the 6q25.1 Locus and Breast Cancer Risk

Association between single nucleotide polymorphism rs9534275 and the risk of coronary artery disease and ischemic stroke

Association of Rs1008805 Polymorphism in the Cyp19a1 Gene with the Prognosis of Early Breast Cancer.

Peer Review #1 of "association Between the CASC16 Rs4784227 Polymorphism and Breast Cancer Risk and Prognosis in a Northeast Chinese Han Population (V0.1)"

Association Between ESR1 Gene Polymorphisms and Breast Cancer Risk

Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs

Current Evidence on the Association Between Rs3757318 of C6orf97 and Breast Cancer Risk: a Meta-Analysis.

CXCL12 Rs266085 and TNF-α Rs1799724 Polymorphisms and Susceptibility to Cervical Cancer in a Chinese Population.

Association Between CASC16 Rs4784227 Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis.

A Polymorphism Rs12325489c>t in the Lincrna-Enst00000515084 Exon Was Found to Modulate Breast Cancer Risk Via GWAS-based Association Analyses.

XRCC 1 Rs 1799782 ( C 194 T ) Polymorphism Correlated with Tumor Metastasis and Molecular Subtypes in Breast Cancer

Quantitative Assessment of the Association Between Rs2046210 at 6q25.1 and Breast Cancer Risk.

Polymorphisms of XRCC2 gene and breast cancer risk : a case-control study in Han women of northwest China

Frequent Mutation of Rs13281615 and Its Association with PVT1 Expression and Cell Proliferation in Breast Cancer